Search Results - "Kislyakov, V. A."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease by Tikhomirova, A S, Kislyakov, V A, Baykova, I E, Nikitin, I G

    Published in Terapevtic̆eskii arhiv (15-02-2018)
    “…Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and its detection in the general population has reached a global scale…”
    Get full text
    Journal Article
  2. 2

    Interleukin-1 is a Biological Marker in Heart Failure by Alieva, A. M., Kislyakov, V. A., Voronkova, K. V., Reznik, E. V., Arakelyan, R. A., Saryev, M. N., Valiev, R. K., Rakhaev, A. M., Hasanova, E. T., Kalova, M. R., Nikitin, I. G.

    Published in Arkhivʺ vnutrenneĭ medit͡s︡iny (01-12-2022)
    “…Inflammation is a universal response of a living organism to various damaging factors and is aimed at restoring tissue integrity and minimizing cell death…”
    Get full text
    Journal Article
  3. 3

    Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism by Nikitin, I. G., Tikhomirova, A. S., Zhinzhilo, T. A., Vinnitskaya, E. V., Sandler, Y. G., Kislyakov, V. A., Fedorov, I. G.

    Published in Arkhivʺ vnutrenneĭ medit͡s︡iny (31-03-2020)
    “…Relevance: Non-alcoholic fatty liver disease is the most common liver disease worldwide. Although the disease usually has a favorable, asymptomatic course, in…”
    Get full text
    Journal Article
  4. 4

    Galactin-3: diagnostic and prognostic value in patients with chronic heart failure by Aliyeva, A M, Baykova, I E, Kislyakov, V A, Gasanova, E T, Almazova, I I, Pinchuk, T V, Fedulayev, Yu N, Zhbanov, I V, Perevertov, V A, Kovtyukh, I V, Nikitin, I G, Reznik, E V

    Published in Terapevtic̆eskii arhiv (15-09-2019)
    “…Now there is a relevant development of the new biomarkers capable to serve as the instrument of early diagnostics of a disease for the purpose of selection of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Telaprevir: new possibilities for antiviral treatment in patients with chronic hepatitis C by Nikitin, I G, Gogova, L M, Baikova, I E, Kislyakov, V A, Volynkina, V M

    Published in Terapevtic̆eskii arhiv (01-01-2012)
    “…The review considers the chemical structure, pharmacodynamics and pharmacokinetics of telaprevir, a new direct-acting antiviral agent, used to treat patients…”
    Get full text
    Journal Article
  7. 7

    Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism by Nikitin, I. G., Tikhomirova, A. S., Zhinzhilo, T. A., Vinnitskaya, E. V., Sandler, Y. G., Kislyakov, V. A., Fedorov, I. G.

    Published in Arkhivʺ vnutrenneĭ medit͡s︡iny (31-03-2020)
    “…Relevance: Non-alcoholic fatty liver disease is the most common liver disease worldwide. Although the disease usually has a favorable, asymptomatic course, in…”
    Get full text
    Journal Article
  8. 8

    Results of application ultrasonic therapy in treatment of relapses of ulcers and purulent complications of the diabetic foots by V A Kislyakov

    “…Have applied ultrasonic therapy device URSK-7N-22 during surgical treatment at 25 patients with relapses of ulcers and it is purulent complications of a…”
    Get full text
    Journal Article
  9. 9

    The influence citokines in relapses of purulently complications at the diabetic foots and opportunities immunokorection by V A Kislyakov

    “…Studying of influence citokines in relapses of purulently complications at patients with a diabetic foots will allow to understand their function in…”
    Get full text
    Journal Article
  10. 10

    Operations of foots at patiens with diabetes - as factor risk of relapses of ulcers and purulent complications by V A Kislyakov

    “…After operations of foots with ulcers and purulent complications at sick of a diabetes, there are relapses. 107 cases are analyzed. Relapses arise because of…”
    Get full text
    Journal Article
  11. 11

    Boceprevir: new possibilities for antiviral treatment of chronic hepatitis C by Nikitin, I G, Baĭkova, I E, Gogova, L M, Volynkina, V M, Kisliakov, V A

    Published in Terapevtic̆eskii arhiv (01-01-2013)
    “…The given clinical review covers current antiviral therapy for chronic hepatitis C. Traditional antiviral therapy with pegylated interferon-alpha and ribavirin…”
    Get full text
    Journal Article
  12. 12
  13. 13